Exploring the Therapeutic Potential of Rosemary Compounds Against Alzheimer's Disease Through GC-MS and Molecular Docking Analysis

Overview

Journal In Silico Pharmacol

Date 2024 Jul 22

PMID 39035101

Authors

Anjali Singh

Dhananjay Singh

Neeraj Tiwari

Pooja Mittal

Mohammed Haris Siddiqui

Nishu Mittal

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-024-00238-9.

Citing Articles

Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols.

Tauil R, Golono P, de Lima E, de Alvares Goulart R, Landgraf Guiguer E, Bechara M Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458995 PMC: 11510109. DOI: 10.3390/ph17101354.

References

Llorens-Martin M, Jurado J, Hernandez F, Avila J . GSK-3β, a pivotal kinase in Alzheimer disease. Front Mol Neurosci. 2014; 7:46. PMC: 4033045. DOI: 10.3389/fnmol.2014.00046. View

Wojtunik-Kulesza K, Kasprzak K, Oniszczuk T, Oniszczuk A . Natural Monoterpenes: Much More than Only a Scent. Chem Biodivers. 2019; 16(12):e1900434. DOI: 10.1002/cbdv.201900434. View

Bazzari F, Bazzari A . BACE1 Inhibitors for Alzheimer's Disease: The Past, Present and Any Future?. Molecules. 2022; 27(24). PMC: 9785888. DOI: 10.3390/molecules27248823. View

Andrade S, Ramalho M, Loureiro J, Pereira M . Interaction of natural compounds with biomembrane models: A biophysical approach for the Alzheimer's disease therapy. Colloids Surf B Biointerfaces. 2019; 180:83-92. DOI: 10.1016/j.colsurfb.2019.04.019. View

Rai S, Tiwari N, Singh P, Singh A, Mishra D, Imran M . Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease. Oxid Med Cell Longev. 2022; 2022:3012778. PMC: 9453010. DOI: 10.1155/2022/3012778. View

Ghalayini J, Boulianne G . Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using models of Alzheimer's disease. Front Neurosci. 2023; 17:1166973. PMC: 10126366. DOI: 10.3389/fnins.2023.1166973. View

Griebel G, Stemmelin J, Lopez-Grancha M, Boulay D, Boquet G, Slowinski F . The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents. Sci Rep. 2019; 9(1):18045. PMC: 6888874. DOI: 10.1038/s41598-019-54557-5. View

Moussa-Pacha N, Abdin S, Omar H, Alniss H, Al-Tel T . BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease. Med Res Rev. 2019; 40(1):339-384. DOI: 10.1002/med.21622. View

Das B, Yan R . Role of BACE1 in Alzheimer's synaptic function. Transl Neurodegener. 2017; 6:23. PMC: 5575945. DOI: 10.1186/s40035-017-0093-5. View

10.

Kushwaha P, Singh V, Somvanshi P, Bhardwaj T, Barreto G, Ashraf G . Identification of new BACE1 inhibitors for treating Alzheimer's disease. J Mol Model. 2021; 27(2):58. DOI: 10.1007/s00894-021-04679-3. View

11.

Lovestone S, Boada M, Dubois B, Hull M, Rinne J, Huppertz H . A phase II trial of tideglusib in Alzheimer's disease. J Alzheimers Dis. 2014; 45(1):75-88. DOI: 10.3233/JAD-141959. View

12.

Palomo V, Martinez A . Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015). Expert Opin Ther Pat. 2016; 27(6):657-666. DOI: 10.1080/13543776.2017.1259412. View

13.

Cragg G, Newman D . Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013; 1830(6):3670-95. PMC: 3672862. DOI: 10.1016/j.bbagen.2013.02.008. View

14.

Tan S, Karri V, Rong Tay N, Chang K, Ah H, Ng P . Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease. Biomed Pharmacother. 2019; 111:765-777. DOI: 10.1016/j.biopha.2018.12.101. View

15.

Bai L, Song N, Yu J, Tan L, Shen Y, Xie J . Elevated plasma levels of soluble TNFRs and TACE activity in Alzheimer's disease patients of Northern Han Chinese descent. Curr Alzheimer Res. 2013; 10(1):57-62. View

16.

Sharma V, Singh T, Garg N, Dhiman S, Gupta S, Rahman M . Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?. Biomolecules. 2021; 11(5). PMC: 8147174. DOI: 10.3390/biom11050678. View

17.

Tan C, Yu J, Wang H, Tan M, Meng X, Wang C . Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014; 41(2):615-31. DOI: 10.3233/JAD-132690. View

18.

Haass C . Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J. 2004; 23(3):483-8. PMC: 1271800. DOI: 10.1038/sj.emboj.7600061. View

19.

Cole S, Vassar R . The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener. 2007; 2:22. PMC: 2211305. DOI: 10.1186/1750-1326-2-22. View

20.

Wilson 3rd D, Cookson M, Van Den Bosch L, Zetterberg H, Holtzman D, Dewachter I . Hallmarks of neurodegenerative diseases. Cell. 2023; 186(4):693-714. DOI: 10.1016/j.cell.2022.12.032. View